Noel Barnard
Conseiller Juridique Général chez VELOXIS PHARMACEUTICALS A/S
Profil
Noel Barnard is currently working as the General Counsel & Vice President-Legal at Veloxis Pharmaceuticals A.
Previously, Noel worked as the Assistant General Counsel at Cornerstone Therapeutics, Inc. from 2013 to 2016.
Noel completed their undergraduate degree at the University of Tennessee in 2008 and graduated from UNC School of Law.
Postes actifs de Noel Barnard
| Sociétés | Poste | Début |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Conseiller Juridique Général | 01/03/2016 |
Anciens postes connus de Noel Barnard
| Sociétés | Poste | Fin |
|---|---|---|
| CORNERSTONE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2016 |
Formation de Noel Barnard
| University of Tennessee | Undergraduate Degree |
| UNC School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
